Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis.


Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
06 2019
Historique:
received: 23 01 2019
revised: 04 03 2019
accepted: 04 03 2019
pubmed: 20 3 2019
medline: 16 7 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Gene and protein expression profiles of iris biopsies, aqueous humor (AqH), and sera in patients with juvenile idiopathic arthritis-associated uveitis (JIAU) in comparison to control patients with primary open-angle glaucoma (POAG) and HLA-B27-positive acute anterior uveitis (AAU) were investigated. Via RNA Sequencing (RNA-Seq) and mass spectrometry-based protein expression analyses 136 genes and 56 proteins could be identified as being significantly differentially expressed (DE) between the JIAU and POAG group. Gene expression of different immunoglobulin (Ig) components as well as of the B cell-associated factors ID3, ID1, and EBF1 was significantly upregulated in the JIAU group as compared to POAG patients. qRT-PCR analysis showed a significantly higher gene expression of the B cell-related genes CD19, CD20, CD27, CD138, and MZB1 in the JIAU group. At the protein level, a significantly higher expression of Ig components in JIAU than in POAG was confirmed. The B cell-associated protein MZB1 showed a higher expression in JIAU patients than in POAG which was confirmed by western blot analysis. Using bead-based immunoassay analysis we were able to detect a significantly higher concentration of the B cell-activating and survival factors BAFF, APRIL, and IL-6 in the AqH of JIAU and AAU patients than in POAG patients. The intraocularly upregulated B cell-specific genes and proteins in iris tissue suggest that B cells participate in the immunopathology of JIAU. The intracameral environment in JIAU may facilitate local effector and survival functions of B cells, leading to disease course typical for anterior uveitis.

Identifiants

pubmed: 30885419
pii: S0896-8411(19)30038-1
doi: 10.1016/j.jaut.2019.03.004
pii:
doi:

Substances chimiques

Eye Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-83

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Lena Wildschütz (L)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany. Electronic address: lena.wildschuetz@uveitis-zentrum.de.

Doreen Ackermann (D)

Interdisciplinary Center for Clinical Research, Core Unit Proteomics, University of Münster, Germany.

Anika Witten (A)

Core Facility Genomics, University of Münster, Germany.

Maren Kasper (M)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.

Martin Busch (M)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.

Shirin Glander (S)

Core Facility Genomics, University of Münster, Germany.

Harutyun Melkonyan (H)

Institute of Experimental Ophthalmology at University of Münster, Germany.

Karoline Walscheid (K)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.

Christoph Tappeiner (C)

Department of Ophthalmology, Inselspital, University of Bern, Bern, Switzerland.

Solon Thanos (S)

Institute of Experimental Ophthalmology at University of Münster, Germany.

Andrei Barysenka (A)

Core Facility Genomics, University of Münster, Germany.

Jörg Koch (J)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.

Carsten Heinz (C)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany; Department of Ophthalmology, University of Duisburg-Essen, Essen, Germany.

Björn Laffer (B)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany; Department of Ophthalmology, University of Duisburg-Essen, Essen, Germany.

Dirk Bauer (D)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.

Monika Stoll (M)

Core Facility Genomics, University of Münster, Germany.

Simone König (S)

Interdisciplinary Center for Clinical Research, Core Unit Proteomics, University of Münster, Germany.

Arnd Heiligenhaus (A)

Department of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany; Department of Ophthalmology, University of Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH